Skip to content

Clinical trials

Completed Nervous System Diseases trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nervous System Diseases Status: Completed Country / region: United Kingdom Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20132
20143
20152
20164
20171
20182
20192
20201
20224
20233
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GenSight Biologics4
University College, London3
NHS Lothian2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
Abcuro, Inc.1
Azafaros B.V.1
Baxalta now part of Shire1
Contineum Therapeutics1
Eli Lilly and Company1
Inmune Bio, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nervous System Diseases28
Genetic Diseases, Inborn8
Neurodegenerative Diseases6
Neuromuscular Diseases6
Brain Diseases5
Central Nervous System Diseases4
Eye Diseases4
Eye Diseases, Hereditary4
Mental Disorders4
Mitochondrial Diseases4

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.